Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
Study NCT ID:
NCT00320918
Status:
TERMINATED
Last Update Posted:
2024-01-12
First Post:
2006-04-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Sponsor:
University of New Mexico
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
ACTUAL
Primary Completion Date:
2006-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-28
First Submit QC Date:
None
Study First Post Date:
2006-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-10
Last Update Post Date:
2024-01-12
Last Update Post Date Type:
ACTUAL